Frameshift variants in C10orf71 cause dilated cardiomyopathy in human, mouse, and organoid models
Open Access
- 17 June 2024
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 134 (12)
Abstract
Research advances over the past 30 years have confirmed a critical role for genetics in the etiology of dilated cardiomyopathies (DCMs). However, full knowledge of the genetic architecture of DCM remains incomplete. We identified candidate DCM causal gene, C10orf71, in a large family with 8 patients with DCM by whole-exome sequencing. Four loss-of-function variants of C10orf71 were subsequently identified in an additional group of492 patients with sporadic DCM from 2 independent cohorts. C10orf71 was found to be an intrinsically disordered protein specifically expressed in cardiomyocytes. C10orf71 -KO mice had abnormal heart morphogenesis during embryonic development and cardiac dysfunction as adults with altered expression and splicing of contractile cardiac genes. C10orf71 -null cardiomyocytes exhibited impaired contractile function with unaffected sarcomere structure. Cardiomyocytes and heart organoids derived from human induced pluripotent stem cells with C10orf71 frameshift variants also had contractile defects with normal electrophysiological activity. A rescue study using a cardiac myosin activator, omecamtiv mecarbil, restored contractile function in C10orf71 -KO mice. These data support C10orf71 as a causal gene for DCM by contributing to the contractile function of cardiomyocytes. Mutation-specific pathophysiology may suggest therapeutic targets and more individualized therapy.Keywords
Funding Information
- National Natural Science Foundation of China (82171835,81800218,82230013)
- Key Laboratory of Remodeling-Related Cardiovascular Diseases, Ministry of Education, China (PXM2014-014226-000012)
- Beijing Municipal Public Welfare Development and Reform Pilot Project for Medical Research Institutes (JYY2023-9)
- National Human Genome Research Institute, the National Eye Institute, and the National Heart, Lung and Blood Institute grant (UM1HG008900)
- National Human Genome Research Institute grant (R01HG009141)
This publication has 34 references indexed in Scilit:
- Sarcomere protein modulation: The new frontier in cardiovascular medicine and beyondEuropean Journal of Internal Medicine, 2022
- On the Potential of Machine Learning to Examine the Relationship Between Sequence, Structure, Dynamics and Function of Intrinsically Disordered ProteinsJournal of Molecular Biology, 2021
- Whole-exome sequencing reveals genetic risks of early-onset sporadic dilated cardiomyopathy in the Chinese Han populationScience China Life Sciences, 2021
- Induced pluripotent stem cell line (ZZUNEUi011-A) derived from peripheral blood mononuclear cells (PBMCs) of a healthy 27-year-old female individualStem Cell Research, 2021
- Omecamtiv Mecarbil in Chronic Heart Failure With Reduced Ejection FractionJACC: Heart Failure, 2020
- 3D bioprinted functional and contractile cardiac tissue constructsActa Biomaterialia, 2018
- Acute Treatment With Omecamtiv Mecarbil to Increase Contractility in Acute Heart FailureJACC, 2016
- Genetic Evaluation of Dilated CardiomyopathyCurrent Cardiology Reports, 2013
- Unusual biophysics of intrinsically disordered proteinsBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2013
- Inherited CardiomyopathiesThe Journal of Molecular Diagnostics, 2013